Practice Performance Partners

Most optometrists know the AREDS2 formula. The more difficult question is how to apply the evidence when the patient sitting in front of us does not fit neatly into a single category.

This course moves beyond simply memorizing a supplement label. We will examine the AREDS and AREDS2 evidence, the role of zinc, lutein, zeaxanthin, and meso-zeaxanthin, and what studies such as CREST can—and cannot—tell us about macular pigment and visual function.

You will learn how to:

• Match supplementation recommendations to the patient’s stage of AMD
• Explain the difference between early nutritional intervention and the established AREDS2 indication
• Evaluate the evidence surrounding zinc dosage
• Understand the potential role of meso-zeaxanthin
• Separate reasonable clinical inference from claims that exceed the evidence
• Have clearer conversations with patients about nutrition, supplementation, and expectations

The objective is not to recommend the same product to every patient. It is to make a defensible recommendation based on disease stage, available evidence, and the clinical objective.

Enroll now and develop a more evidence-based approach to AMD supplementation.